Literature DB >> 11934598

Differential integrin expression by cardiac fibroblasts from hypertensive and exercise-trained rat hearts.

Maria Lonnett Burgess1, Louis Terracio, Toshiro Hirozane, Thomas K Borg.   

Abstract

The cardiac fibroblast is the principal cell type responsible for extracellular matrix (ECM) synthesis in the heart during growth and pathophysiological conditions. A dynamic interaction exists between the cardiac ECM and fibroblasts that is sensitive to the local mechanical and chemical tissue environment. We propose here that cardiac fibroblasts structurally and functionally adapt to changing local environments by altering their expression of receptor integrins. Changes in the extracellular environment are communicated in part by integrins, which link the ECM to the cell and regulate phenotype and function. In this report, we analyze integrin protein expression, migration and gel contraction by cardiac fibroblasts from rats subjected to 10 weeks of treadmill exercise (XTR), experimental hypertension (HYP) or controls (CONT). Immunoprecipitation shows that beta1 protein increases in XTR and HYP. Also, alpha1 and alpha2 integrins are lower in XTR and HYP, and alpha5 integrin is higher in XTR and lower in HYP. Functional assays show that XTR and HYP migrate slower on collagen, while XTR migrate faster and HYP slower on fibronectin. Cell isolation procedure, population expansion number or a general adaptation to culture conditions does not explain the differences observed. No significant differences in collagen gel contraction are detected. These results indicate that cardiac fibroblasts retain their in vivo patterns in vitro for a limited number of population expansions. This tissue-specific phenotype is exhibited in early passage (< or =6). However, by late passage (>8), cells begin to show adaptation to the in vitro conditions. These results show that cardiac fibroblasts respond to changing environments in pathophysiological conditions by modulating integrin expression, which is associated with changes in cell migration. They also suggest a pragmatic use for primary cardiac fibroblasts as a model to study the cardiac matrix remodeled by physiological (exercise) and pathological (hypertension) stressors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934598     DOI: 10.1016/s1054-8807(01)00104-1

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  24 in total

1.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

Review 2.  Origin of cardiac fibroblasts and the role of periostin.

Authors:  Paige Snider; Kara N Standley; Jian Wang; Mohamad Azhar; Thomas Doetschman; Simon J Conway
Journal:  Circ Res       Date:  2009-11-06       Impact factor: 17.367

3.  Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.

Authors:  Xiaoyi Zhang; James A Stewart; Ian D Kane; Erin P Massey; Dawn O Cashatt; Wayne E Carver
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-12       Impact factor: 2.416

4.  Effects of interleukin-33 on cardiac fibroblast gene expression and activity.

Authors:  Jinyu Zhu; Wayne Carver
Journal:  Cytokine       Date:  2012-03-23       Impact factor: 3.861

5.  Tryptase/Protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts.

Authors:  Jennifer L McLarty; Giselle C Meléndez; Gregory L Brower; Joseph S Janicki; Scott P Levick
Journal:  Hypertension       Date:  2011-07-05       Impact factor: 10.190

6.  Effects of interleukin-18 on cardiac fibroblast function and gene expression.

Authors:  Charity Fix; Kellie Bingham; Wayne Carver
Journal:  Cytokine       Date:  2010-11-02       Impact factor: 3.861

7.  Temporal alterations in cardiac fibroblast function following induction of pressure overload.

Authors:  James A Stewart; Erin P Massey; Charity Fix; Jinyu Zhu; Edie C Goldsmith; Wayne Carver
Journal:  Cell Tissue Res       Date:  2010-03-09       Impact factor: 5.249

Review 8.  Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease.

Authors:  Alison K Schroer; W David Merryman
Journal:  J Cell Sci       Date:  2015-04-27       Impact factor: 5.285

9.  Activation of cardiac fibroblasts by ethanol is blocked by TGF-β inhibition.

Authors:  Brittany A Law; Wayne E Carver
Journal:  Alcohol Clin Exp Res       Date:  2013-03-25       Impact factor: 3.455

10.  Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts.

Authors:  Vennece Fowlkes; Jessica Clark; Charity Fix; Brittany A Law; Mary O Morales; Xian Qiao; Kayla Ako-Asare; Jack G Goldsmith; Wayne Carver; David B Murray; Edie C Goldsmith
Journal:  Life Sci       Date:  2013-01-16       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.